Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β(2) Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study
布地奈德/福莫特罗抗炎缓解和维持剂或丙酸氟替卡松/沙美特罗加按需使用的短效β2受体激动剂:在未达到最佳控制哮喘的患者中的真实世界疗效(REACT)研究
期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S266177
Cheng, Shih-Lung; Ho, Ming-Lin; Lai, Yun-Fa; Wang, Hao-Chien; Hsu, Jeng-Yuan; Liu, Shih-Feng; Huang, Ming-Shyang; Lee, Cheng-Hung; Lin, Ching-Hsiung; Hang, Liang-Wen; Liu, Yu-Chih; Yang, Kuang-Yao; Wang, Jia-Horng